Patent · US Active

Method of treating cancer cells

US11129867B2 · kind B2 · utility

0Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2019
Grant dateSep 28, 2021
Priority date
Expiry dateFeb 1, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA63F2300/60
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses a method of treating cancer cells. The method comprises administrating a composition comprises a rhodamine or rhodamine derivative conjugated to a peptide comprises an amino acid sequence of SEQ ID NO: 1 to a subject in need, and activate the composition with light.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.